Clinical Trials at Stanford University Medical Center
As of September 2026, 34 paid clinical trials are recruiting at Stanford University Medical Center, located at 300 PASTEUR DRIVE, ROOM A343 DEPARTMENT OF NEUROLOGY, STANFORD, CA 94305-5235, phone (650) 725-6688 in Stanford, California. Active studies at this site cover conditions such as Autism Spectrum Disorder, Autism and Atrial Fibrillation. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Stanford
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
35 clinical trials at Stanford University Medical Center
·Clear filters·A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Fabry Disease Registry & Pregnancy Sub-registry
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
CAR-T Long Term Follow Up (LTFU) Study
PARTNER 3 Trial - Aortic Valve-in-Valve
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
CARES (Comprehensive Analgesic, Recovery, and Education Support) for Surgery Trial
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
StrokeNet Thrombectomy Endovascular Platform
TrialNet Pathway to Prevention of T1D
Safety and Durability of Sirolimus for Treatment of LAM
Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction
Common conditions studied in Stanford
- Autism Spectrum Disorder (17 active studies)
- Autism (12 active studies)
- Atrial Fibrillation (7 active studies)
- Breast Cancer (7 active studies)
- Cancer (7 active studies)
- Heart Failure (6 active studies)
Leading research sponsors in Stanford
- Stanford University
- Eli Lilly and Company
- AstraZeneca
- Memorial Sloan Kettering Cancer Center
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Stanford?
There are approximately 427 recruiting clinical trials in Stanford, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stanford pay participants?
Most recruiting trials in Stanford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stanford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stanford?
The most common conditions under active study in Stanford include Autism Spectrum Disorder (17), Autism (12), Atrial Fibrillation (7), Breast Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stanford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stanford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stanford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stanford?
Recruiting research sites in Stanford include Stanford University, Stanford University School of Medicine, Stanford University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stanford right now?
The largest active categories in Stanford are Cancer & tumors (84), Cardiovascular (43), Neurology & pain (37). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Stanford University Medical Center?
Stanford University Medical Center is located at 300 PASTEUR DRIVE, ROOM A343 DEPARTMENT OF NEUROLOGY, STANFORD, CA 94305-5235. Use the Google Maps link in the intro above to get directions.
How do I contact Stanford University Medical Center?
You can reach Stanford University Medical Center by phone at (650) 725-6688. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.